Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Nuedexta Paragraph 4: We Are confident in IP Position to 2026
-
Canaccord Genuity reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Nuedexta First Four Months: Slow but Solid, Steady Growth
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Management Dinner Takeaways
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Senate Nuedexta Price Inquiry; Don't See Real Risk
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Q2/11: Slow Start to Nuedexta Launch
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Nuedexta at AAN: Gaining Visibility, Staying the Course
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Nuedexta Launch: First Six Weeks Modest, But Very Preliminary
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Targeted Nuedexta US Launch Rolling; We See Key Sales Inflection Point In Q4'11
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Management Dinner Takeaways: Nuedexta Launch, Commercial Strategy Shaping Up
-
Canaccord Genuity Morning Coffee on AVANIR Pharma (AVNR): Now There’s a Party
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Queuing Up the Nuedexta Launch for February 2011
-
Canaccord Genuity Morning Coffee on Avanir Pharma (AVNR): Approved – Game On!
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Nuedexta Approved
-
Canaccord Genuity Morning Coffee on Avanir Pharma (AVNR): Expecting a VERY HAPPY Halloween
-
Canaccord Genuity Morning Coffee: Avanir Pharma (AVNR) Happy Halloween?
-
Canaccord Genuity Raises Price Target On Avanir Pharmaceuticals (AVNR) to $9
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); 923 Approvability Underscored by More Safety Data at ANA
